February 5, 2015 / 8:15 AM / in 3 years

BRIEF-Almirall agrees for AstraZeneca to buy US and Canada rights for aclidinium bromide

Feb 5 (Reuters) - Almirall SA :

* Says agrees for AstraZeneca to acquire the US and Canada rights for aclidinium bromide from Actavis

* Says upon completion of transaction, AstraZeneca will own development and commercial rights in US and Canada to Tudorza Pressair for chronic obstructive pulmonary disease (COPD)

* Says AstraZeneca will assume development rights and obligations in US and Canada for LA40464, approved in the EU under the brand name Duaklir Genuair Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below